Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use

Details for Australian Patent Application No. 2009223613 (hide)

Owner Children's Hospital & Research Center at Oakland Novartis Vaccines and Diagnostics, SRL.

Inventors Beernink, Peter; Welsch, Jo Anne; Granoff, Dan

Agent FB Rice

Pub. Number AU-A-2009223613

PCT Pub. Number WO2009/114485

Priority 61/035,329 10.03.08 US; 61/037,252 17.03.08 US

Filing date 9 March 2009

Wipo publication date 17 September 2009

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/114485 Priority application(s): WO2009/114485

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223615-Use of siRNA to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide

2009223607-Interspinous process spacer instrument system with deployment indicator